Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Ascending Doses of XC243 After Single and Multiple Oral Administration in Healthy Volunteers.
Clinical trial NCT05628116 · COMPLETED
Trial details
- NCT number
- NCT05628116
- Sponsor
- PHARMENTERPRISES LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-28
- Primary completion
- 2023-09-21
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.